Skip to main content

Effect of MK-329 on Pancreatic Secretion in Man

  • Chapter

Abstract

The relative importance of hormonal and neural factors in the regulation of pancreatic exocrine secretion in man has been much debated. Circulating cholecystokinin (CCK) is generally regarded as an important stimulant of the postprandial pancreatic enzyme output based on studies where the enzyme response to physiological doses of exogenous CCK have been compared to the food stimulated response [1,2]. Most of these studies have concluded that postprandial elevations in plasma CCK concentrations are sufficient to produce the pancreatic enzyme secretion normally occurring after a meal. However, such evidence does not prove conclusively that CCK is the sole, or major, physiologic regulator of pancreatic enzyme secretion compared to other hormonal or neural factors.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Beglinger C, Fried M, Whitehouse I, Jansen JB, Lamers CB, Gyr K (1985) Pancreatic enzyme response to a liquid meal and to hormonal stimulation. J Clin Invest 75:1471–1476

    Article  PubMed  CAS  Google Scholar 

  2. Cantor P (1989) Cholecystokinin in plasma. Digestion 42:181–201

    Article  PubMed  Google Scholar 

  3. Lotti VJ, Pendleton RG, Gould RJ, Hanson HM, Chang RSL, Clineschmidt BJ (1987) In vivo pharmacology of L-364718, a new potent nonpeptide peripheral cholecystokinin antagonist. J Pharmacol Exp Ther 241:103–109

    PubMed  CAS  Google Scholar 

  4. Pendleton RG, Bendesky RJ, Schaffer L, Nolan TE, Gould RJ, Clineschmidt BJ (1987) Roles of endogenous cholecystokinin in biliary, pancreatic and gastric function: studies with L-364718, a specific cholecystokinin receptor antagonist. J Pharmacol Exp Ther 241:210–216

    Google Scholar 

  5. Liddle RA, Gertz BA, Kanyama S, Beccaria L, Coker LD, Turnbull TA, Morita ET (1989) Effects of a novel cholecystokinin receptor antagonist, MK-329, on gallbladder contraction and gastric emptying in humans: implications for the physiology of CCK. J Clin Invest 84:1220–1225

    Article  PubMed  CAS  Google Scholar 

  6. Cantor P, Olsen O, Gertz BJ, Gjorup I, Worning H (1991) Inhibition of cholecystokinin (CCK)-stimulated pancreaticobiliary output in man by the CCK-receptor antagonist MK-329. Scand J Gastroenterol 26:627–637

    Article  PubMed  CAS  Google Scholar 

  7. Cantor P, Mortensen PE, Myhre J, Gjorup I, Worning H, Stahl E, Survill TT (1990) The effect of the cholecystokinin receptor antagonist MK-329 on meal-stimulated pancreatico-biliary output and gastrointestinal motility in man. gastroenterology (submitted)

    Google Scholar 

  8. Myhre J, Mortensen PE, Astrup A, Worning H (1988) Normal human pancreatic secretion after ingestion of a solid meal. Digestion 40:103–104

    Google Scholar 

  9. Hildebrand P, Beglinger C, Gyr K, Jansen JBMJ, Rovati LC, Zuercher M, Lamers CBHW, Setnikar I, Stalder GA (1990) Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man. J Clin Invest 85:640–646

    Article  PubMed  CAS  Google Scholar 

  10. Adler G, Reinshagen M, Koop I, Arnold R, Rovati L (1988) Inhibition of stimulated pancreatic secretion in man by a cholecystokinin antagonist (CR 1505). Digestion 40:67

    Article  Google Scholar 

  11. Meyer BM, Beglinger C, Jansen JBMJ, Rovati LC, Werth BA, Hildebrand P, Zach D, Stalder GA (1989) Role of cholecystokinin in regulation of gastrointestinal motor functions. Lancet 2:12–15

    Article  PubMed  CAS  Google Scholar 

  12. Chang RSL, Lotti VJ (1986) Biochemical and pharmacologic characterization of a new extremely potent and selective nonpeptide cholecystokinin antagonist. Proc Natl Acad Sci USA 83:4923–4926

    Article  PubMed  CAS  Google Scholar 

  13. Von Schrenck T, Moran TH, Heinz-Erian P, Gardner JD, Jensen RT (1988) Cholecystokinin receptors on gallbladder muscle and pancreatic acinar cells: a comparative study. Am J Physiol 255:G512–G521

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Cantor, P. (1991). Effect of MK-329 on Pancreatic Secretion in Man. In: Adler, G., Beglinger, C. (eds) Cholecystokinin Antagonists in Gastroenterology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76362-5_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-76362-5_13

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-76364-9

  • Online ISBN: 978-3-642-76362-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics